Branched-chain amino acid catabolism breaks glutamine addiction to sustain hepatocellular carcinoma progression
Dongdong Yang,Haiying Liu,Yongping Cai,Kangyang Lu,Xiuying Zhong,Songge Xing,Wei Song,Yaping Zhang,Ling Ye,Xia Zhu,Ting Wang,Pinggen Zhang,Shi-Ting Li,Jiaqian Feng,Weidong Jia,Huafeng Zhang,Ping Gao
DOI: https://doi.org/10.1016/j.celrep.2022.111691
IF: 8.8
2022-11-23
Cell Reports
Abstract:Branched-chain amino acid (BCAA) catabolism is related to tumorigenesis. However, the underlying mechanism and specific contexts in which BCAAs affect tumor progression remain unclear. Here, we demonstrate that BCAA catabolism is activated in liver cancer cells without glutamine. Enhanced BCAA catabolism leads to BCAA-derived carbon and nitrogen flow toward nucleotide synthesis, stimulating cell-cycle progression and promoting cell survival. Mechanistically, O-GlcNAcylation increases under glutamine-deprivation conditions and stabilizes the PPM1K protein, leading to dephosphorylation of BCKDHA and enhanced decomposition of BCAAs. Dephosphorylation of BCKDHA and high expression of PPM1K promote tumorigenesis in vitro and in vivo and are closely related to the poor prognosis of clinical patients with hepatocellular carcinoma (HCC). Inhibition of BCAA and glutamine metabolism can further retard HCC growth in vivo . These results not only elucidate a mechanism by which BCAA catabolism affects tumorigenesis but also identify pBCKDHA and PPM1K as potential therapeutic targets and predictive biomarkers. Introduction Cancer cells exhibit an altered metabolism compared with that of normal cells, a phenomenon called metabolic reprogramming, which is crucial to tumor survival and proliferation. Recent studies have revealed that, in addition to glucose and glutamine, other nutrients for the production of energy and/or building blocks for cells also have potential roles in the reprogrammed metabolic state of many cancer cells; among these components are branched-chain amino acids (BCAAs). BCAAs are critically involved in cancer progression; however, the relevant mechanistic details remain unclear and controversial (Hattori et al., 2017 Hattori A. Tsunoda M. Konuma T. Kobayashi M. Nagy T. Glushka J. Tayyari F. McSkimming D. Kannan N. Tojo A. et al. Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia. Nature. 2017; 545 : 500-504 https://doi.org/10.1038/nature22314 Crossref PubMed Scopus (189) Google Scholar ; Li et al., 2020 Li J.T. Yin M. Wang D. Wang J. Lei M.Z. Zhang Y. Liu Y. Zhang L. Zou S.W. Hu L.P. et al. BCAT2-mediated BCAA catabolism is critical for development of pancreatic ductal adenocarcinoma. Nat. Cell Biol. 2020; 22 : 167-174 https://doi.org/10.1038/s41556-019-0455-6 Crossref PubMed Scopus (65) Google Scholar ; Mayers et al., 2016 Mayers J.R. Torrence M.E. Danai L.V. Papagiannakopoulos T. Davidson S.M. Bauer M.R. Lau A.N. Ji B.W. Dixit P.D. Hosios A.M. et al. Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers. Science. 2016; 353 : 1161-1165 https://doi.org/10.1126/science.aaf5171 Crossref PubMed Scopus (334) Google Scholar ; Tonjes et al., 2013 Tönjes M. Barbus S. Park Y.J. Wang W. Schlotter M. Lindroth A.M. Pleier S.V. < -Abstract Truncated-
cell biology